Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex
Alexander D. Shaw, Neeraj K. Saxena, Laura E. Jackson, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 8, pp. 1136-1146
Closed Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener, Mark J. Niciu, Elizabeth D. Ballard, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 10, pp. 886-897
Open Access | Times Cited: 405
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 285
Gamma oscillations as a biomarker for major depression: an emerging topic
Paul J. Fitzgerald, Brendon O. Watson
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 277
Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans
Suresh Muthukumaraswamy, Alexander D. Shaw, Laura E. Jackson, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 33, pp. 11694-11706
Open Access | Times Cited: 221
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent, Elizabeth D. Ballard, Todd D. Gould, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 1040-1052
Open Access | Times Cited: 216
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 47
Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
Tineke Grent-’t-Jong, Joachim Groß, Jozien Goense, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 145
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Panos Zanos, Jaclyn N. Highland, Brent W. Stewart, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 13, pp. 6441-6450
Open Access | Times Cited: 127
Progesterone – Friend or foe?
Inger Sundström Poromaa, Erika Comasco, Rachael L. Sumner, et al.
Frontiers in Neuroendocrinology (2020) Vol. 59, pp. 100856-100856
Open Access | Times Cited: 125
Neurophysiologic Correlates of Ketamine Sedation and Anesthesia
Phillip E. Vlisides, Tarik Bel‐Bahar, UnCheol Lee, et al.
Anesthesiology (2017) Vol. 127, Iss. 1, pp. 58-69
Open Access | Times Cited: 102
A Comprehensive Overview of the Role of Visual Cortex Malfunction in Depressive Disorders: Opportunities and Challenges
Fangfang Wu, Qing-Bo Lu, Yan Kong, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 9, pp. 1426-1438
Open Access | Times Cited: 30
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
Jared M. Kopelman, Timothy A. Keller, Benjamin Panny, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
Gia Han Le, Sabrina Wong, Sebastian Badulescu, et al.
Journal of Affective Disorders (2024) Vol. 355, pp. 342-354
Closed Access | Times Cited: 9
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Dawn F. Ionescu, Julia M. Felicione, Aishwarya Gosai, et al.
Harvard Review of Psychiatry (2018) Vol. 26, Iss. 6, pp. 320-339
Open Access | Times Cited: 81
Isoflurane and ketamine differentially influence spontaneous and evoked laminar electrophysiology in mouse V1
Nicholas J. Michelson, Takashi D.Y. Kozai
Journal of Neurophysiology (2018) Vol. 120, Iss. 5, pp. 2232-2245
Open Access | Times Cited: 74
On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations
Diego Lozano‐Soldevilla
Frontiers in Computational Neuroscience (2018) Vol. 12
Open Access | Times Cited: 68
Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
Cristan Farmer, Jessica R. Gilbert, Ruin Moaddel, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1398-1404
Open Access | Times Cited: 68
Rapid-acting antidepressants
Jeffrey M. Witkin, Anna Martin, Lalit K. Golani, et al.
Advances in pharmacology (2019), pp. 47-96
Closed Access | Times Cited: 61
The Reuniens Nucleus of the Thalamus Has an Essential Role in Coordinating Slow-Wave Activity between Neocortex and Hippocampus
Brandon E. Hauer, Silvia Pagliardini, Clayton T. Dickson
eNeuro (2019) Vol. 6, Iss. 5, pp. ENEURO.0365-19.2019
Open Access | Times Cited: 56
Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation
Jessica R. Gilbert, Carlos A. Zarate
Pharmacology Biochemistry and Behavior (2020) Vol. 189, pp. 172856-172856
Open Access | Times Cited: 53
Reinstating olfactory bulb-derived limbic gamma oscillations alleviates depression-like behavioral deficits in rodents
Qun Li, Yuichi Takeuchi, Jiale Wang, et al.
Neuron (2023) Vol. 111, Iss. 13, pp. 2065-2075.e5
Open Access | Times Cited: 16
Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling
Jessica R. Gilbert, Julia S. Yarrington, Kathleen E. Wills, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 8, pp. 740-747
Open Access | Times Cited: 54
Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia
Tineke Grent-’t-Jong, Davide Rivolta, Joachim Groß, et al.
Brain (2018) Vol. 141, Iss. 8, pp. 2511-2526
Open Access | Times Cited: 54
Glutamatergic Deficits in Schizophrenia – Biomarkers and Pharmacological Interventions within the Ketamine Model
Moritz Haaf, Gregor Leicht, Stjepan Ćurić, et al.
Current Pharmaceutical Biotechnology (2018) Vol. 19, Iss. 4, pp. 293-307
Open Access | Times Cited: 46
The neurophysiology of ketamine: an integrative review
Rebecca McMillan, Suresh Muthukumaraswamy
Reviews in the Neurosciences (2020) Vol. 31, Iss. 5, pp. 457-503
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top